FDA 510(k)

EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)

Número K: K234042 · 2024-06-07

Data da decisão2024-06-07

Código do produtoQIH

Comité consultivoRA

DecisãoSubstantially Equivalent

Resumo do dispositivo

EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) is the device name listed in this FDA 510(k) record. The listed applicant is Ever Fortune.Ai, Co., Ltd.. It received FDA 510(k) clearance on 2024-06-07 under 510(k) number K234042. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Perguntas frequentes

What is the EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)?

EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) is a medical device that received FDA 510(k) clearance on 2024-06-07. The listed applicant is Ever Fortune.Ai, Co., Ltd.. The 510(k) number is K234042.

When did EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) receive FDA 510(k) clearance?

EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) received FDA 510(k) clearance on 2024-06-07, under 510(k) number K234042.

Who is the listed applicant for EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)?

The FDA 510(k) record lists Ever Fortune.Ai, Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)?

The FDA product code for EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) is QIH.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Outros registros que listam Ever Fortune.Ai, Co., Ltd. como candidato(a)

K253163EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100)K251306Seg Pro V3 (RT-300)K242821EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)K241923EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)K240291EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM K231025EFAI NeuroSuite CT ICH Assessment System

Ver todos os 15 dispositivos →

Dispositivos Relacionados (Código: QIH)

K260055syngo.CT Brain QuantificationSiemens Medical Solutions USA, Inc.K262390BoneXpertVisiana K261368Rapid Platform (R6.7)Ischemaview, Inc.K261623EchoPAC Software Only / EchoPAC Plug-in (v211)GE Medical Systems Ultrasound and Primary Care Diagnostics K261677Artificial Intelligence Renal Assessment (AIRA) Version 1Aramis Global AI Consultancies, LLC K2608794DMINVIA, LLC

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.